<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">47362</article-id><article-id pub-id-type="doi">10.7554/eLife.47362</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group></article-categories><title-group><article-title>Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-136918"><name><surname>Pech</surname><given-names>Matthew</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1451-0234</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-150130"><name><surname>Fong</surname><given-names>Linda E</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-138607"><name><surname>Villalta</surname><given-names>Jacqueline E</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-138608"><name><surname>Chan</surname><given-names>Leanne JG</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf5"/></contrib><contrib contrib-type="author" id="author-138609"><name><surname>Kharbanda</surname><given-names>Samir</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf6"/></contrib><contrib contrib-type="author" id="author-124345"><name><surname>O'Brien</surname><given-names>Jonathon J</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9660-4797</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf7"/></contrib><contrib contrib-type="author" id="author-124343"><name><surname>McAllister</surname><given-names>Fiona E</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf8"/></contrib><contrib contrib-type="author" id="author-138610"><name><surname>Firestone</surname><given-names>Ari J.</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf9"/></contrib><contrib contrib-type="author" id="author-47423"><name><surname>Jan</surname><given-names>Calvin H</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9033-4028</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf10"/></contrib><contrib contrib-type="author" corresp="yes" id="author-52143"><name><surname>Settleman</surname><given-names>Jeffrey</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3569-6493</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf11"/></contrib><aff id="aff1"><institution content-type="dept">Department of Oncology</institution>, <institution>Calico Life Sciences LLC</institution>, <addr-line><named-content content-type="city">South San Francisco</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Proteomics</institution>, <institution>Calico Life Sciences LLC</institution>, <addr-line><named-content content-type="city">South San Francisco</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Department of Research</institution>, <institution>Calico Life Sciences LLC</institution>, <addr-line><named-content content-type="city">South San Francisco</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Department of Oncology</institution>, <institution>Calico Life Sciences LLC</institution>, <addr-line><named-content content-type="city">San Diego</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-34218"><name><surname>Jonjic</surname><given-names>Stipan</given-names></name><role>Reviewing editor</role><aff><institution>University Rijeka</institution>, <country>Croatia</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>jsettleman@gmail.com</email> (JS);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>27</day><month>08</month><year>2019</year></pub-date><volume>8</volume><elocation-id>e47362</elocation-id><history><date date-type="received"><day>03</day><month>04</month><year>2019</year></date><date date-type="accepted"><day>02</day><month>08</month><year>2019</year></date></history><permissions><copyright-statement>Â© 2019, Pech et al</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Pech et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-47362-v1.pdf"/><abstract><p>Only a subset of cancer patients respond to T-cell checkpoint inhibitors, highlighting the need for alternative immunotherapeutics. We performed CRISPR-Cas9 screens in a leukemia cell line to identify perturbations that enhance natural killer effector functions. Our screens defined critical components of the tumor-immune synapse and highlighted the importance of cancer cell interferon-g signaling in modulating NK activity. Surprisingly, disrupting the ubiquitin ligase substrate adaptor DCAF15 strongly sensitized cancer cells to NK-mediated clearance. DCAF15 disruption induced an inflamed state in leukemic cells, including increased expression of lymphocyte costimulatory molecules. Proteomic and biochemical analysis revealed that cohesin complex members were endogenous client substrates of DCAF15. Genetic disruption of DCAF15 was phenocopied by treatment with indisulam, an anticancer drug that functions through DCAF15 engagement. In AML patients, reduced DCAF15 expression was associated with improved survival. These findings suggest that DCAF15 inhibition may have useful immunomodulatory properties in the treatment of myeloid neoplasms.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>Calico Life Sciences LLC</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Pech</surname><given-names>Matthew</given-names></name><name><surname>Fong</surname><given-names>Linda E</given-names></name><name><surname>Villalta</surname><given-names>Jacqueline E</given-names></name><name><surname>Chan</surname><given-names>Leanne JG</given-names></name><name><surname>Kharbanda</surname><given-names>Samir</given-names></name><name><surname>O'Brien</surname><given-names>Jonathon J</given-names></name><name><surname>McAllister</surname><given-names>Fiona E</given-names></name><name><surname>Firestone</surname><given-names>Ari J.</given-names></name><name><surname>Jan</surname><given-names>Calvin H</given-names></name><name><surname>Settleman</surname><given-names>Jeffrey</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Matthew Pech, employee of Calico Life Sciences, LLC.</p></fn><fn fn-type="conflict" id="conf3"><p>Linda E Fong, employee of Calico Life Sciences, LLC.</p></fn><fn fn-type="conflict" id="conf4"><p>Jacqueline E Villalta, employee of Calico Life Sciences, LLC.</p></fn><fn fn-type="conflict" id="conf5"><p>Leanne JG Chan, employee of Calico Life Sciences, LLC.</p></fn><fn fn-type="conflict" id="conf6"><p>Samir Kharbanda, employee of Calico Life Sciences, LLC.</p></fn><fn fn-type="conflict" id="conf7"><p>Jonathon J O'Brien, employee of Calico Life Sciences, LLC.</p></fn><fn fn-type="conflict" id="conf8"><p>Fiona E McAllister, employee of Calico Life Sciences, LLC.</p></fn><fn fn-type="conflict" id="conf9"><p>Ari J. Firestone, employee of Calico Life Sciences, LLC.</p></fn><fn fn-type="conflict" id="conf10"><p>Calvin H Jan, employee of Calico Life Sciences, LLC.</p></fn><fn fn-type="conflict" id="conf11"><p>Jeffrey Settleman, employee of Calico Life Sciences, LLC; Senior editor, <italic>eLife</italic>.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Sequencing data have been deposited in GEO under accession code GSE134173.All data generated or analyzed during this study are included in the manuscript and supporting files.Figure 1C: Table S2Figure 2D: Table S3Figure 4F: Table S4Figure 7C: Table S6</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Pech M</collab><collab>Settleman J</collab></person-group><year iso-8601-date="2019">2019</year><source>Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE134173">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE134173</ext-link><comment>NCBI Gene Expression Omnibus, GSE134173</comment></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation id="dataset2" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Bolouri H</collab><collab>Farrar JE</collab><collab>Triche T Jr</collab><collab>Ries RE</collab><collab>Lim EL</collab><collab>Alonzo TA</collab><collab>Ma Y</collab><collab>Moore R</collab><collab>Mungall AJ</collab><collab>Marra MA</collab><collab>Zhang J</collab><collab>Ma X</collab><collab>Liu Y</collab><collab>Liu Y</collab><collab>Auvil JMG</collab><collab>Davidsen TM</collab><collab>Gesuwan P</collab><collab>Hermida LC</collab><collab>Salhia B</collab><collab>Capone S Ramsingh G</collab><collab>Zwaan CM</collab><collab>Noort S</collab><collab>Piccolo SR</collab><collab>Kolb EA</collab><collab>Gamis AS</collab><collab>Smith MA</collab><collab>Gerhard DS</collab><collab>Meshinchi S</collab></person-group><year iso-8601-date="2018">2018</year><source>TARGET AML RNAseq and clinical data</source><ext-link ext-link-type="uri" xlink:href="https://portal.gdc.cancer.gov">https://portal.gdc.cancer.gov</ext-link><comment>TARGET AML</comment></element-citation><element-citation id="dataset3" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Cancer Genome Atlas Research Network</collab><collab>Ley TJ</collab><collab>Miller C</collab><collab>Ding L</collab><collab>Raphael BJ</collab><collab>Mungall AJ</collab><collab>Robertson A</collab><collab>Hoadley K</collab><collab>Triche TJ Jr</collab><collab>Laird PW</collab><collab>Baty JD</collab><collab>Fulton LL</collab><collab>Fulton R</collab><collab>Heath SE</collab><collab>Kalicki-Veizer J</collab><collab>Kandoth C</collab><collab>Klco JM</collab><collab>Koboldt DC</collab><collab>Kanchi KL</collab><collab>Kulkarni S</collab><collab>Lamprecht TL</collab><collab>Larson DE</collab><collab>Lin L</collab><collab>Lu C</collab><collab>McLellan MD</collab><collab>McMichael JF</collab><collab>Payton J</collab><collab>Schmidt H</collab><collab>Spencer DH</collab><collab>Tomasson MH</collab><collab>Wallis JW</collab><collab>Wartman LD</collab><collab>Watson MA</collab><collab>Welch J</collab><collab>Wendl MC</collab><collab>Ally A</collab><collab>Balasundaram M</collab><collab>Birol I</collab><collab>Butterfield Y</collab><collab>Chiu R</collab><collab>Chu A</collab><collab>Chuah E</collab><collab>Chun HJ</collab><collab>Corbett R</collab><collab>Dhalla N</collab><collab>Guin R</collab><collab>He A</collab><collab>Hirst C</collab><collab>Hirst M</collab><collab>Holt RA</collab><collab>Jones S</collab><collab>Karsan A</collab><collab>Lee D</collab><collab>Li HI</collab><collab>Marra MA</collab><collab>Mayo M</collab><collab>Moore RA</collab><collab>Mungall K</collab><collab>Parker J</collab><collab>Pleasance E</collab><collab>Plettner P</collab><collab>Schein J</collab><collab>Stoll D</collab><collab>Swanson L</collab><collab>Tam A</collab><collab>Thiessen N</collab><collab>Varhol R</collab><collab>Wye N</collab><collab>Zhao Y</collab><collab>Gabriel S</collab><collab>Getz G</collab><collab>Sougnez C</collab><collab>Zou L</collab><collab>Leiserson MD</collab><collab>Vandin F</collab><collab>Wu HT</collab><collab>Applebaum F</collab><collab>Baylin SB</collab><collab>Akbani R</collab><collab>Broom BM</collab><collab>Chen K</collab><collab>Motter TC</collab><collab>Nguyen K</collab><collab>Weinstein JN</collab><collab>Zhang N</collab><collab>Ferguson ML</collab><collab>Adams C</collab><collab>Black A</collab><collab>Bowen J</collab><collab>Gastier-Foster J</collab><collab>Grossman T</collab><collab>Lichtenberg T</collab><collab>Wise L</collab><collab>Davidsen T</collab><collab>Demchok JA</collab><collab>Shaw KR</collab><collab>Sheth M</collab><collab>Sofia HJ</collab><collab>Yang L</collab><collab>Downing JR</collab><collab>Eley G</collab></person-group><year iso-8601-date="2013">2013</year><source>TCGA LAML RNAseq and clinical data</source><ext-link ext-link-type="uri" xlink:href="https://portal.gdc.cancer.gov">https://portal.gdc.cancer.gov</ext-link><comment>TCGA LAML</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-47362-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>